[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364436-105":59,"doc-detail-364436-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-effect-of-hrhpv-prevalence-on-cervical-cancer-screening-strategies-a-cost-effectiveness-study-of-bangladesh","The effect of hrHPV prevalence on cervical cancer screening strategies - a cost-effectiveness study of Bangladesh","","Study evaluates how hrHPV prevalence influences the cost-effectiveness of cervical cancer screening in Bangladesh as an example for low- and middle-income countries. It compares two approaches from a health system perspective: self-sampling hrHPV testing followed by visual inspection with acetic acid (VIA), versus VIA as primary screening followed by colposcopy. A micro-simulation Markov model tests strategies under optimal (70%) and realistic (8.7%) uptake scenarios across different hrHPV prevalence rates. Results show prevented cervical cancer cases and cost-effectiveness increase with higher hrHPV prevalence. The hrHPV test plus VIA strategy prevents more cancers than VIA plus colposcopy in most instances and remains cost-effective compared with no screening across 2–30% prevalence; lower hrHPV test prices improve life-year gains.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-effect-of-hrhpv-prevalence-on-cervical-cancer-screening-strategies-a-cost-effectiveness-study-of-bangladesh/364436/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-effect-of-hrhpv-prevalence-on-cervical-cancer-screening-strategies-a-cost-effectiveness-study-of-bangladesh/364436.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What screening strategies are compared in the study?","Question",{"text":112,"@type":113},"The study compares self-sampling hrHPV testing followed by VIA versus VIA as the primary screening method followed by colposcopy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does hrHPV prevalence affect cost-effectiveness outcomes?",{"text":117,"@type":113},"Prevented cervical cancer cases and cost-effectiveness increase as hrHPV prevalence increases across tested scenarios.",{"name":119,"@type":110,"acceptedAnswer":120},"In which prevalence range are both strategies cost-effective compared with no screening?",{"text":121,"@type":113},"Both strategies are cost-effective compared with no screening within an hrHPV prevalence range of 2–30%.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364436,1790696727,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Pan etal. BMC Public Health (2025) 25:561 BMC Public Health  \n[https://doi.org/10.1186/s12889-025-21756-x](https://doi.org/10.1186/s12889-025-21756-x)  \nRESEARCH Open Access  \nThe effect of hrHPV prevalence on cervical cancer screening strategies: a costeffectiveness study of Bangladesh  \nFengming Pan 1*, Jurjen van der Schans2,3,4, Naheed Nazrul5, Jaap A. R. Koot2, Jogchum Beltman6, Marcel J. W. Greuter7 and Geertruida [H. de](H. de) Bock1*  \nAbstract  \nBackground Cervical cancer is the second most prominent cancer among women in Bangladesh, which is mainly caused by persistent infection with high-risk human papillomavirus (hrHPV) . This study aims to evaluate impact of hrHPV prevalence on cost-effectiveness of screening with self-sampling hrHPV testing versus visual inspection with acetic acid (VIA) for cervical cancer screening in low-and middle-income countries with Bangladesh as an example. Methods A micro-simulation Markov model was developed from a health system perspective in Bangladesh to evaluate the cost-effectiveness of screening with self-sampling hrHPV testing followed by VIA and VIA as primary screening method followed by col poscopy. We compared these strategies in optimal (70%) and realistic (8 . 7%) uptake scenarios, considering different hrHPV prevalence rates. Key indicators for cost-effectiveness were number of prevented cervical cancers cases and incremental cost-effectiveness ratio (ICER) .  \nResults The number of cervical cancers cases prevented by screening and cost-effectiveness of screening strategies increased as hrHPV prevalence increased. In both optimal and realistic uptake scenarios, hrHPV test + VIA strategy prevented more cancers than VIA +col poscopy strategy in most instances. Regardless of the uptake, both screening strategies were cost-effective compared to no screening within a hrHPV prevalence range of 2–30%, and the hrHPV test-based strategy was cost-effective compared with VIA-based strategy. When the price of hrHPV test was estimated 50% lower (10 USD), the hrHPV test-based strategy gained more life years at nearly the same cost as the VIA-based strategy.  \nConclusions Our study demonstrates that the hrHPV test + VIA strategy is cost-effective both compared to no screening and VIA +col poscopy screening strategy under the optimal (70%) and realistic (8 . 7%) uptake scenarios, with greater cost-effectiveness at higher hrHPV prevalence levels. While VIA-based strategy is cheaper, self-sampling hrHPV test-based strategy offers greater health benefits. Implementing hrHPV testing in national screening programs at lower hrHPV test prices is crucial for promoting health equity and accelerating cervical cancer elimination worldwide. In resource-constrained settings, screening with hrHPV testing should initially target high-prevalence populations.  \n*Correspondence: Fengming Pan [f.pan@umcg.nl](f.pan@umcg.nl)[ ](f.pan@umcg.nl)Geertruida [H. de](H. de) Bock [g.h.de.bock@umcg.nl](g.h.de.bock@umcg.nl)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the c","cbCaisRqklO26mCz","https://ap.wps.com/l/cbCaisRqklO26mCz","pdf",1215608,11,"English","# Abstract\n# Introduction\n## Background on cervical cancer burden\n## Role of persistent hrHPV infection\n## Variation in hrHPV prevalence","[{\"question\":\"What screening strategies are compared in the study?\",\"answer\":\"The study compares self-sampling hrHPV testing followed by VIA versus VIA as the primary screening method followed by colposcopy.\"},{\"question\":\"How does hrHPV prevalence affect cost-effectiveness outcomes?\",\"answer\":\"Prevented cervical cancer cases and cost-effectiveness increase as hrHPV prevalence increases across tested scenarios.\"},{\"question\":\"In which prevalence range are both strategies cost-effective compared with no screening?\",\"answer\":\"Both strategies are cost-effective compared with no screening within an hrHPV prevalence range of 2–30%.\"}]","The effect of hrHPV prevalence on cervical cancer screening strategies - a cost-effectiveness study of Bangladesh | PDF",1790157539,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a357021ab2c78f65f738c42e4d4fb849.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2e5c610906c23d4e3833f9e4d93bdd9a.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ff8ccd7be119faea09c55604add5a19.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a71801ccf205c863a72a67eea070dac7.webp",980,1306]